AvantGuard, Inc.
Pioneering the future of long-term pathogen protection with cutting-edge antimicrobial solutions.
AvantGuard™ pioneers the future of long-term pathogen protection through cutting-edge chemistry. Our antimicrobial solutions provide extended efficacy on a wide range of surfaces, making them ideal for healthcare, food processing, and hospitality industries. Did you know that hospital-acquired infections and food-borne illnesses cost over $100B annually, worldwide? AvantGuard's EPA-registered tech
The team was thrilled to be back at the RESI Boston Innovator's Pitch Challenge (IPC) with Life Science Nation this year! 🎉 Our CEO, Ted Eveleth, had the incredible opportunity to showcase our groundbreaking antimicrobial work. The IPC provided a unique platform to engage with a panel of dedicated investors, receive real-time feedback, and gain valuable insights.
It was an exciting experience to be part of a community driving innovation in life sciences. We’re proud of the progress made and look forward to what’s next for AvantGuard!
September was a busy month for AvantGuard! Our CEO, Ted Eveleth, attended the Disease Prevention & Control Summit America, where global leaders gathered to address the future of infectious disease prevention. It wasn’t just about learning—it was about collaborating and sharing our own groundbreaking work in the fight against antimicrobial resistance (AMR).
At AvantGuard, we’re not just keeping up; we’re leading the charge with innovative technologies that tackle resistant pathogens. We're proud to contribute to these critical conversations and bring new ideas to the table as we continue our mission of advancing global health.
As football season kicks off, keeping athletes safe on and off the field is more important than ever. Did you know that sports can be ideal environments for the spread of bacteria and viruses?
Sweating during games can lead to moisture build-up, promoting the growth of harmful microorganisms. Infections like MRSA, an antibiotic-resistant bacteria, are a serious concern in sports communities. By regularly cleaning sports gear, sanitizing locker rooms, and prioritizing personal hygiene, we can help protect athletes and staff.
AvantGuard's innovative antimicrobial technology has the potential to transform sports’ safety by being applied to equipment or used as a temporary coating, keeping surfaces germ-free for longer. This not only reduces infection risks but also cuts down on cleaning costs.
Play safe and stay protected! Learn more about AvantGuard’s technology at the link in our bio.
Imagine a world where everyday personal care products offer enhanced protection and freshness. AvantGuard's cutting-edge technology holds the potential to transform oral mouthwashes, deodorants, soaps, and even preservatives for creams and color cosmetics. By integrating our advanced antimicrobial solutions, these products could provide not only improved efficacy but also longer-lasting protection.
As we advance, AvantGuard is committed to exploring these exciting possibilities to elevate your personal care routine. Stay tuned for updates on how our innovative technology could redefine hygiene and safety in your daily life.
A perfect storm is brewing in global infectious diseases.
Today:
– Healthcare-acquired infections cost society $25-40 billion annually.
– Fungal infections affect over a billion people every year.
– Climate change is exacerbating these threats.
Tomorrow:
– By 2050, drug-resistant pathogens could claim more lives than cancer.
– Climate change will continue to drive the rise of fungal infections.
– Drug resistance is on the rise, threatening our future.
Continuing with current options is a losing game.
But what if we could harness our body's natural response to prevent and treat infectious diseases without causing antimicrobial resistance? The future of infection control may be closer than we think. Stay tuned as AvantGuard explores innovative solutions that could change the game.
AvantGuard, Inc. is a finalist in the RESI Boston Innovator's Pitch Challenge (IPC) with Life Science Nation!
Join us this Wednesday, September 25, at the The Westin Copley Place, where our CEO, Ted Eveleth, will showcase our groundbreaking work. The IPC is a unique opportunity for innovators like us to shine, with each pitch session featuring interactive Q&A from a dedicated panel of investors.
This is not your typical conference presentation – the IPC allows for real-time feedback and engagement from active investors, providing invaluable insights and exposure.
Stay tuned as we work towards revolutionizing antimicrobial technology!
Avantamine™ is revolutionizing the way we combat harmful microorganisms. This broad-spectrum biocide not only eliminates all pathogens—including viruses, Gram-positive and Gram-negative bacteria, yeast, and fungi—but also tackles their biofilms, ensuring thorough and long-lasting protection.
What sets Avantamine™ apart is its remarkable safety profile. Unlike traditional chlorinated products, Avantamine™ delivers powerful pathogen elimination without causing corrosion or irritation, making it safe for use on all surfaces, including skin.
Experience the future of pathogen defense with Avantamine™—effective, safe, and designed for every environment. Learn more about how Avantamine™ is changing the game in germ control at the link in our bio.
AvantGuard’s CEO, Ted Eveleth, will be presenting at the MedInvest Biotech & Pharma Investor Conference in New York City, September 18-19, 2024. This event gathers top venture capitalists, pharma executives, and biotech innovators for two days of presentations, panel discussions, and networking with industry leaders.
Ted will showcase AvantGuard’s cutting-edge antimicrobial technologies and share insights on the future of infection control and pathogen protection. With the conference's focus on the future of pathogen defense, this is an incredible opportunity to share our vision for safer healthcare solutions.
Stay tuned as AvantGuard leads the charge in healthcare innovation!
It’s Pollution Prevention Week! Let’s unite to make a difference and reduce pollution in our communities. Pollution prevention starts with us – every choice we make impacts the environment. Whether it's conserving water, saving energy, or making eco-friendly choices, every action counts.
At AvantGuard, we understand the connection between environmental health and other global issues like the rise in fungal infections driven by climate change. Our mission is to combat these challenges with innovative antimicrobial solutions that not only protect against pathogens but also align with sustainable practices.
By supporting pollution prevention efforts and adopting advanced technologies, we can contribute to a healthier planet and a safer future.
Learn more about how you can make a positive impact at https://www.epa.gov/p2week
Pollution Prevention Week | US EPA Pollution Prevention (P2) Week highlights the efforts making pollution prevention a cornerstone of sustainability.
As we face the growing threat of resistant pathogens, like Clostridioides difficile and Candida auris, the need for advanced protection has never been more urgent. Candida auris, in particular, poses a severe challenge with its 50% mortality rate and resistance to multiple antifungal drugs.
With the efficacy of antibiotics waning, it’s crucial to innovate and develop new defenses. At AvantGuard, we’re tackling this global crisis head-on. Our cutting-edge antimicrobial products are designed to provide long-term protection against a wide range of pathogens, offering a promising solution in the fight against infectious diseases.
Contact us or visit our website to learn more about how AvantGuard is contributing to the next generation of pathogen protection.
Biofilms significantly contribute to the development of antimicrobial resistance, especially in healthcare facilities. These complex communities of bacteria and other microorganisms adhere to surfaces and create a protective matrix that shields pathogens from antibiotics and disinfectants. This protective barrier not only makes infections harder to treat but also accelerates the development of resistance, posing a serious threat to patient safety. AvantGuard's innovative solutions, are designed to break down and eliminate these resilient biofilms, ensuring that pathogens – and their resistance mechanisms – are effectively neutralized. Discover how we’re pioneering new ways to safeguard healthcare environments.
At AvantGuard, we're paving the way for a future where advanced antimicrobial technology is accessible to everyone—from healthcare experts to families at home. If our cutting-edge solutions are designed to meet the rigorous demands of hospitals and wound care, imagine the peace of mind they could bring to your everyday life.
We’re excited to envision a world where AvantGuard's innovations protect the spaces and surfaces you interact with daily. Stay tuned as we work towards making this future a reality!
Understanding the difference between cleaning, disinfecting, and sanitizing is key to maintaining a safe and healthy environment. Here’s a quick guide:
– Cleaning removes dirt, germs, and impurities from surfaces but doesn’t necessarily kill them.
– Disinfecting kills most germs, including bacteria and viruses, on surfaces.
– Sanitizing reduces bacteria to levels public health codes or regulations consider safe.
Remember:
1. Not all disinfectants kill all germs. Always check the label for effectiveness.
2. Disinfection claims vary, so choose products carefully.
3. Residual protection is ideal. Look for solutions that provide longer-lasting protection without chemicals that easily wipe off.
Regularly clean and disinfect high-touch surfaces and follow product instructions for the best results. Stay safe!
As we honor the hard work and dedication of individuals everywhere, AvantGuard is here to lighten your load with our innovative technology. Whether it's at home, in the workplace, or out in the community, our solutions tirelessly create cleaner, safer spaces for you.
This Labor Day, while you enjoy your well-deserved break, let AvantGuard handle the rest—keeping surfaces protected from harmful pathogens. Your health and safety are our top priorities, so let's embrace a future where innovation works as hard as you do.
Happy Labor Day! Relax and let AvantGuard keep your environment healthier.
"The data from our research is clear: AvantGuard binds with chlorine molecules to hold chlorine in place on treated surfaces to provide around-the-clock antimicrobial protection in a safe and effective manner that does not damage surfaces or irritate skin. Our technology represents another tool in the way the world protects itself from pathogens.”
– Ted Eveleth, CEO AvantGuard
AvantGuard is revolutionizing both wound care and medical devices with our groundbreaking Avantamine™ technology. Harnessing the power of chlorine without the usual corrosion or safety concerns, Avantamine mimics our body's natural defenses, making it highly effective against bacterial and fungal infections and their biofilms. Our biocompatible treatments are gentle on the skin, ensuring efficacy without compromising safety and preventing resistance generation, thereby preserving antibiotics for critical needs.
Unlike static solutions, Avantamine provides dynamic antimicrobial action, effectively eradicating bacteria, viruses, and fungi while preventing biofilm buildup. With its chlorine-holding capabilities, our technology offers extended protection for months.
Join us in shaping the future of wound care and medical devices!
Join us at the Military Health System Research Symposium (MHSRS) from August 26-29, where AvantGuard's CEO, Ted Eveleth, will be presenting a poster on our latest advancements. The MHSRS is the Department of Defense's premier scientific meeting, focused on the unique medical needs of the Warfighter. This event is a great opportunity to connect with military medical professionals, researchers, and industry leaders dedicated to enhancing Warfighter health and readiness.
Don't miss out on this chance to learn how AvantGuard is contributing to innovative solutions for military wound care.
Antimicrobial resistance (AMR) not only poses a grave threat to public health but also carries significant economic consequences. By 2030, AMR could result in trillions of dollars in economic damage and push millions into poverty. AvantGuard recognizes the urgency of addressing AMR's multifaceted impact and remains committed to driving positive change.
Discover the power of Avantamine™, the superior chloramine solution from AvantGuard. Retaining all the benefits of chlorinated biocides, Avantamine™ offers broad-spectrum efficacy, quick kill, and no resistance generation. It outperforms antibiotics and antifungals, proving significantly better against bacteria and 50 times more effective than traditional antifungal treatments.
Our studies show Avantamine™ (0.2%) achieves higher log reduction of ex vivo biofilms for P. aeruginosa and C. albicans compared to triple antibiotic ointment, silver sulfadiazine (1%), and clotrimazole (1%).
Experience the next level of antimicrobial protection with Avantamine™.
Avantamine™ revolutionizes chlorine safety and efficacy. Unlike bleach, which whitens and damages surfaces, Avantamine™ is gentle enough for all surfaces, including skin, while still killing bacteria, fungi, mold, and viruses. See the difference in the picture!
Explore the evolution of AvantGuard, originally known as Halomine, stemming from the pioneering research of S.D. Worley. With a legacy of 40 patents and a career spanning decades, Worley has transformed germ-killing practices across industries.
From water purification to medical bandages, AvantGuard continues to advance Worley's technology, providing sustained antimicrobial power for a cleaner, safer world.
Join us in embracing the future of germ-killing innovation with AvantGuard and honoring S.D. Worley's transformative contributions.
Exciting News! 🎉 AvantGuard has been named a Semi-Finalist in the 2024 Pepperdine University Most Fundable Companies competition! Out of over 2,000 participants, we've made it to the top 100, showcasing our strong potential and growth.
Stay tuned as we progress towards the Finals and the prestigious Pepperdine Graziadio Business School Most Fundable Companies List. Thank you for your continued support!
Learn more on our website here: https://www.avantguardinc.com/post/avantguard-named-semi-finalist-in-2024-pepperdine-most-fundable-companies-competition
Quats, commonly found in public spaces like schools, gyms, and grocery stores, pose a public health problem. These chemicals are in many cleaning products and can be harmful. Make a difference by raising awareness in your community. At home, avoid quats by checking labels for ingredients like benzalkonium chloride and opting for non-antibacterial cleaners. Soon you can choose safer alternatives like AvantGuard for effective and gentle cleaning.
Discover the difference with AvantGuard: It's not just about surface protection – it's about your safety. While other solutions claim to prevent mold and bacteria growth, AvantGuard goes further by actively eliminating harmful pathogens. Our advanced technology provides ongoing defense, ensuring both surface integrity and personal well-being.
Avoid misleading claims. Biostatic protection inhibits microorganism reproduction but doesn't always eradicate contaminants. AvantGuard stands apart, prioritizing effective pathogen elimination to keep environments safe.
Join us in advancing safer spaces. Learn more about AvantGuard's innovative antimicrobial solutions and their lasting benefits on our website.
Join us in celebrating Dr. Carine Nkemngong's latest paper, co-authored with Peter Teska from Diversey, on the critical role of biofilms in healthcare and food processing environments. Biofilms, complex communities of bacteria and fungi, challenge standard disinfectant efficacy tests, potentially leading to antimicrobial resistance. This review explores their prevalence, impact on surface hygiene, and regulatory implications, emphasizing the need for advanced solutions. Read the full publication here: https://www.avantguardinc.com/post/dr-carinen-kemngongs-insights-on-biofilms-and-pathogen-persistence-in-healthcare-and-food-processing
Dr. Carine Nkemngong's Insights on Biofilms and Pathogen Persistence in Healthcare and Food Processing Join us in celebrating Dr. Carine Nkemngong's latest paper, co-authored with Peter Teska from Diversey, on the critical role of biofilms in healthcare and food processing environments. Biofilms, complex communities of bacteria and fungi, challenge standard disinfectant efficacy tests, potentially le...